3 ms·
Biotech investment tanked in 2009, and has barely begun to recover. Every statistic I've seen says that valley software companies are still getting the lion's
by timr 16y ago
Biotech investment tanked in 2009, and has barely begun to recover. Every statistic I've seen says that valley software companies are still getting the lion's share of VC investment:
http://www.fiercebiotech.com/story/biotech-vc-investing-grows-3-percent-2010/2011-01-21 http://www.fiercebiotech.com/story/biotech-vc-investing-grow...
http://www.siliconvalley.com/venture-capital-survey/ci_17416341?nclick_check=1 http://www.siliconvalley.com/venture-capital-survey/ci_17416...
- prostoalex 16y agoFrom a 2010 report http://www.jointventure.org/images/stories/pdf/2010%20Index-final.pdf http://www.jointventure.org/images/stories/pdf/2010%20Index-... a relevant graph http://moskalyuk.name/wp-content/uploads/2010/04/image13.png http://moskalyuk.name/wp-content/uploads/2010/04/image13.png By number of deals you're right, software is huge, but by dollar amounts Better Place and others certainly raised the bar for cleantech just by attracting nine-digit sums.
- timr 16y agoBoth of the articles I linked say that software is the largest VC target by dollars invested.